68 related articles for article (PubMed ID: 28323888)
1. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.
Kwabi-Addo B; Giri D; Schmidt K; Podsypanina K; Parsons R; Greenberg N; Ittmann M
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11563-8. PubMed ID: 11553783
[TBL] [Abstract][Full Text] [Related]
2. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of LZTS2 by PLK1 activates the Wnt pathway.
Liu R; Zhou D; Yu B; Zhou Z
Cell Signal; 2024 May; 120():111226. PubMed ID: 38740232
[TBL] [Abstract][Full Text] [Related]
4. Pten regulates endocytic trafficking of cell adhesion and Wnt signaling molecules to pattern the retina.
Touahri Y; Hanna J; Tachibana N; Okawa S; Liu H; David LA; Olender T; Vasan L; Pak A; Mehta DN; Chinchalongporn V; Balakrishnan A; Cantrup R; Dixit R; Mattar P; Saleh F; Ilnytskyy Y; Murshed M; Mains PE; Kovalchuk I; Lefebvre JL; Leong HS; Cayouette M; Wang C; Del Sol A; Brand M; Reese BE; Schuurmans C
Cell Rep; 2024 Apr; 43(4):114005. PubMed ID: 38551961
[TBL] [Abstract][Full Text] [Related]
5. PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription.
Liang H; Chen X; Yin Q; Ruan D; Zhao X; Zhang C; McNutt MA; Yin Y
Nat Commun; 2017 Mar; 8():14771. PubMed ID: 28332494
[TBL] [Abstract][Full Text] [Related]
6. RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression.
Dong Z; Li J; Dai W; Yu D; Zhao Y; Liu S; Li X; Zhang Z; Zhang R; Liang X; Kong Q; Jin S; Jiang H; Jiang W; Ding C
Cell Death Dis; 2023 Feb; 14(2):89. PubMed ID: 36750557
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer.
Koushyar S; Meniel VS; Phesse TJ; Pearson HB
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204808
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
[TBL] [Abstract][Full Text] [Related]
9. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
10. PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around.
Gkountakos A; Sartori G; Falcone I; Piro G; Ciuffreda L; Carbone C; Tortora G; Scarpa A; Bria E; Milella M; Rosell R; Corbo V; Pilotto S
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31404976
[TBL] [Abstract][Full Text] [Related]
11. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Cell Biochem Funct; 2018 Jun; 36(4):194-202. PubMed ID: 29653464
[TBL] [Abstract][Full Text] [Related]
13. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z
PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888
[TBL] [Abstract][Full Text] [Related]
14. LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin.
Thyssen G; Li TH; Lehmann L; Zhuo M; Sharma M; Sun Z
Mol Cell Biol; 2006 Dec; 26(23):8857-67. PubMed ID: 17000760
[TBL] [Abstract][Full Text] [Related]
15. The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development.
Peng Y; Clark C; Luong R; Tu WH; Lee J; Johnson DT; Das A; Carroll TJ; Sun Z
J Biol Chem; 2011 Nov; 286(46):40331-42. PubMed ID: 21949185
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
17. Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.
Ugalde-Olano A; Egia A; Fernández-Ruiz S; Loizaga-Iriarte A; Zuñiga-García P; Garcia S; Royo F; Lacasa-Viscasillas I; Castro E; Cortazar AR; Zabala-Letona A; Martín-Martín N; Arruabarrena-Aristorena A; Torrano-Moya V; Valcárcel-Jiménez L; Sánchez-Mosquera P; Caro-Maldonado A; González-Tampan J; Cachi-Fuentes G; Bilbao E; Montero R; Fernández S; Arrieta E; Zorroza K; Castillo-Martín M; Serra V; Salazar E; Macías-Cámara N; Tabernero J; Baselga J; Cordón-Cardo C; Aransay AM; Villar AD; Iovanna JL; Falcón-Pérez JM; Unda M; Bilbao R; Carracedo A
Methods; 2015 May; 77-78():25-30. PubMed ID: 25697760
[TBL] [Abstract][Full Text] [Related]
18. Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.
Irshad S; Abate-Shen C
Cancer Metastasis Rev; 2013 Jun; 32(1-2):109-22. PubMed ID: 23114843
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
